• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cy5.5 标记的亲和体分子用于表皮生长因子受体阳性肿瘤的近红外荧光光学成像。

Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.

机构信息

Stanford University, Stanford Cancer Center, Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, 1201 Welch Road, Lucas Expansion, P095, Stanford, California 94305-5344, USA.

出版信息

J Biomed Opt. 2010 May-Jun;15(3):036007. doi: 10.1117/1.3432738.

DOI:10.1117/1.3432738
PMID:20615009
Abstract

Affibody protein is an engineered protein scaffold with a three-helical bundle structure. Affibody molecules of small size (7 kD) have great potential for targeting overexpressed cancer biomarkers in vivo. To develop an Affibody-based molecular probe for in vivo optical imaging of epidermal growth factor receptor (EGFR) positive tumors, an anti-EGFR Affibody molecule, Ac-Cys-Z(EGFR:1907) (7 kD), is site-specifically conjugated with a near-IR fluorescence dye, Cy5.5-mono-maleimide. Using fluorescent microscopy, the binding specificity of the probe Cy5.5-Z(EGFR:1907) is checked by a high-EGFR-expressing A431 cell and low-EGFR-expressing MCF7 cells. The binding affinity of Cy5.5-Z(EGFR:1907) (K(D)) to EGFR is 43.6+/-8.4 nM, as determined by flow cytometry. For an in vivo imaging study, the probe shows fast tumor targeting and good tumor contrast as early as 0.5 h postinjection (p.i.) for A431 tumors, while MCF7 tumors are barely visible. An ex vivo imaging study also demonstrates that Cy5.5-Z(EGFR:1907) has high tumor, liver, and kidney uptakes at 24 h p.i.. In conclusion, Cy5.5-Z(EGFR:1907) shows good affinity and high specificity to the EGFR. There is rapid achievement of good tumor-to-normal-tissue contrasts of Cy5.5-Z(EGFR:1907), thus demonstrating its potential for EGFR-targeted molecular imaging of cancers.

摘要

亲和体蛋白是一种具有三螺旋束结构的工程化蛋白支架。亲和体分子体积小(7kD),在体内靶向过表达的癌症生物标志物方面具有巨大潜力。为了开发基于亲和体的分子探针用于表皮生长因子受体(EGFR)阳性肿瘤的体内光学成像,一种抗-EGFR 亲和体分子 Ac-Cys-Z(EGFR:1907)(7kD)被特异性地与近红外荧光染料 Cy5.5-单马来酰亚胺偶联。使用荧光显微镜,通过高 EGFR 表达的 A431 细胞和低 EGFR 表达的 MCF7 细胞检查探针 Cy5.5-Z(EGFR:1907)的结合特异性。通过流式细胞术确定 Cy5.5-Z(EGFR:1907)(K(D))与 EGFR 的结合亲和力为 43.6+/-8.4 nM。在体内成像研究中,探针在 A431 肿瘤中早在注射后 0.5 小时(p.i.)即可快速靶向肿瘤并具有良好的肿瘤对比度,而 MCF7 肿瘤几乎不可见。离体成像研究还表明,Cy5.5-Z(EGFR:1907)在注射后 24 小时具有高肿瘤、肝和肾摄取率。总之,Cy5.5-Z(EGFR:1907)对 EGFR 具有良好的亲和力和高特异性。Cy5.5-Z(EGFR:1907)能够迅速达到良好的肿瘤与正常组织对比度,从而证明了其在癌症的 EGFR 靶向分子成像中的潜力。

相似文献

1
Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.Cy5.5 标记的亲和体分子用于表皮生长因子受体阳性肿瘤的近红外荧光光学成像。
J Biomed Opt. 2010 May-Jun;15(3):036007. doi: 10.1117/1.3432738.
2
Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.评价四种基于亲和体的近红外荧光探针用于表皮生长因子受体阳性肿瘤的光学成像。
Bioconjug Chem. 2012 Jun 20;23(6):1149-56. doi: 10.1021/bc200596a. Epub 2012 Jun 4.
3
Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.利用近红外光学成像表征乳腺癌异种移植表皮生长因子受体的表达
Acta Radiol. 2009 Dec;50(10):1095-103. doi: 10.3109/02841850903008800.
4
PET of EGFR expression with an 18F-labeled affibody molecule.用 18F 标记的亲和体分子进行表皮生长因子受体的 PET 显像。
J Nucl Med. 2012 Jul;53(7):1110-8. doi: 10.2967/jnumed.111.100842. Epub 2012 Jun 11.
5
Cy5.5-Ac-Cys-ZCy5.5 - 乙酰化半胱氨酸 - Z
6
Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.乳腺癌异种移植模型中表皮生长因子受体的近红外光学成像
Cancer Res. 2003 Nov 15;63(22):7870-5.
7
Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein.小动物 PET 成像用人表皮生长因子受体阳性肿瘤与 64Cu 标记的亲和体蛋白。
Bioconjug Chem. 2010 May 19;21(5):947-54. doi: 10.1021/bc900515p.
8
In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore.利用近红外荧光染料标记的表皮生长因子受体特异性亲和体分子对异种移植瘤进行体内成像。
Neoplasia. 2010 Feb;12(2):139-49. doi: 10.1593/neo.91446.
9
Near infrared imaging of EGFR of oral squamous cell carcinoma in mice administered arsenic trioxide.三氧化二砷给药后口腔鳞状细胞癌中表皮生长因子受体的近红外成像
PLoS One. 2012;7(9):e46255. doi: 10.1371/journal.pone.0046255. Epub 2012 Sep 28.
10
Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.微剂量水平体内给药的荧光亲和体分子标记表达表皮生长因子受体(EGFR)的胶质瘤肿瘤区域。
Mol Imaging Biol. 2017 Feb;19(1):41-48. doi: 10.1007/s11307-016-0980-7.

引用本文的文献

1
Site-Selective Approaches to Attain Fluorescent Human Insulin Conjugates: Balancing the Site of Labeling and the Activity.获得荧光人胰岛素缀合物的位点选择性方法:平衡标记位点与活性。
ACS Omega. 2025 Feb 17;10(8):8140-8151. doi: 10.1021/acsomega.4c09498. eCollection 2025 Mar 4.
2
Molecular and functional imaging in cancer-targeted therapy: current applications and future directions.癌症靶向治疗中的分子和功能影像学:当前应用及未来方向。
Signal Transduct Target Ther. 2023 Feb 27;8(1):89. doi: 10.1038/s41392-023-01366-y.
3
IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
IRDye800CW标记的靶向尿激酶型纤溶酶原激活物受体(uPAR)的肽用于荧光引导的胶质母细胞瘤手术:原位异种移植的临床前研究
Theranostics. 2021 May 21;11(15):7159-7174. doi: 10.7150/thno.49787. eCollection 2021.
4
Improved surgical resection of metastatic pancreatic cancer using uPAR targeted fluorescent guidance: comparison with traditional white light surgery.使用uPAR靶向荧光引导改善转移性胰腺癌的手术切除:与传统白光手术的比较
Oncotarget. 2019 Oct 29;10(59):6308-6316. doi: 10.18632/oncotarget.27220.
5
Emerging Fluorescent Molecular Tracers to Guide Intra-Operative Surgical Decision-Making.用于指导术中手术决策的新型荧光分子示踪剂
Front Pharmacol. 2019 May 14;10:510. doi: 10.3389/fphar.2019.00510. eCollection 2019.
6
Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules.分析聚焦于亲和体分子的癌症中表皮生长因子受体靶向分子成像的进展和挑战。
Mol Imaging. 2019 Jan-Dec;18:1536012118823473. doi: 10.1177/1536012118823473.
7
Anti-EGFR Affibodies with Site-Specific Photo-Cross-Linker Incorporation Show Both Directed Target-Specific Photoconjugation and Increased Retention in Tumors.抗 EGFR Affibodies 带有定点光交联剂,表现出定向靶特异性光缀合和增加肿瘤保留。
J Am Chem Soc. 2018 Sep 19;140(37):11820-11828. doi: 10.1021/jacs.8b07601. Epub 2018 Sep 11.
8
Evaluation of a Centyrin-Based Near-Infrared Probe for Fluorescence-Guided Surgery of Epidermal Growth Factor Receptor Positive Tumors.基于Centyrin的近红外探针用于表皮生长因子受体阳性肿瘤荧光引导手术的评估
Bioconjug Chem. 2017 Nov 15;28(11):2865-2873. doi: 10.1021/acs.bioconjchem.7b00566. Epub 2017 Oct 17.
9
DNA-Assembled Core-Satellite Upconverting-Metal-Organic Framework Nanoparticle Superstructures for Efficient Photodynamic Therapy.DNA 组装的核-卫星上转换金属有机骨架纳米粒子超结构用于高效光动力疗法。
Small. 2017 Jun;13(24). doi: 10.1002/smll.201700504. Epub 2017 May 8.
10
Robust surface coating for a fast, facile fluorine-18 labeling of iron oxide nanoparticles for PET/MR dual-modality imaging.用于快速简便地对氧化铁纳米颗粒进行氟-18 标记的稳健表面涂层,用于 PET/MR 双模成像。
Nanoscale. 2016 Dec 1;8(47):19644-19653. doi: 10.1039/c6nr07298d.